Effect of Hemodialysis on the Red Blood Cell Life Span in Patients with End‐Stage Kidney Disease
暂无分享,去创建一个
[1] D. Chlubek,et al. The impact of hemodialysis on erythrocyte membrane cytoskeleton proteins. , 2015, Postepy higieny i medycyny doswiadczalnej.
[2] J. Minakuchi,et al. Shortened Red Blood Cell Lifespan Is Related to the Dose of Erythropoiesis‐Stimulating Agents Requirement in Patients on Hemodialysis , 2012, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[3] R. Walker,et al. Red blood cell survival in long-term dialysis patients. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[4] G. Tsagalis. Renal anemia: a nephrologist's view. , 2011, Hippokratia.
[5] P. Dutka. Guarding against hidden hemolysis during dialysis: an overview. , 2008, Nephrology nursing journal : journal of the American Nephrology Nurses' Association.
[6] J. Vienken. Biocompatibility of dialysis membranes , 2006 .
[7] Harold I Feldman,et al. Anemia and mortality in hemodialysis patients: accounting for morbidity and treatment variables updated over time. , 2005, Kidney international.
[8] A. Yılmaz,et al. The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels. , 2004, Mediators of inflammation.
[9] R. Vanholder,et al. Which dialyser membrane to choose? , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[10] S. Ho,et al. Simplification of the end-alveolar carbon monoxide technique to assess erythrocyte survival. , 2003, The Journal of laboratory and clinical medicine.
[11] A. Pascalis,et al. Intra- and post-dialytic platelet activation and PDGF-AB release: cellulose diacetate vs polysulfone membranes. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] C. Wanner,et al. Inflammation and advanced glycation end products in uremia: simple coexistence, potentiation or causal relationship? , 2001, Kidney international. Supplement.
[13] F. Ursini,et al. Oxidant stress in hemodialysis: prevention and treatment strategies. , 2000, Kidney international. Supplement.
[14] E W Young,et al. Dialysis dose, membrane type, and anemia control. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] L. Spry,et al. Multistate outbreak of hemolysis in hemodialysis patients--Nebraska and Maryland, 1998. , 1998, MMWR. Morbidity and mortality weekly report.
[16] C. Ronco,et al. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. , 1996, Kidney international.
[17] M. Levitt,et al. Use of alveolar carbon monoxide measurements to assess red blood cell survival in hemodialysis patients , 1994, American journal of hematology.
[18] R. Engel,et al. A simple carbon monoxide breath test to estimate erythrocyte turnover. , 1992, The Journal of laboratory and clinical medicine.